1. Home
  2. EXAS vs TTAN Comparison

EXAS vs TTAN Comparison

Compare EXAS & TTAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • TTAN
  • Stock Information
  • Founded
  • EXAS 1995
  • TTAN 2012
  • Country
  • EXAS United States
  • TTAN United States
  • Employees
  • EXAS N/A
  • TTAN N/A
  • Industry
  • EXAS Medical Specialities
  • TTAN
  • Sector
  • EXAS Health Care
  • TTAN
  • Exchange
  • EXAS Nasdaq
  • TTAN NYSE
  • Market Cap
  • EXAS 10.7B
  • TTAN 10.2B
  • IPO Year
  • EXAS N/A
  • TTAN 2024
  • Fundamental
  • Price
  • EXAS $53.02
  • TTAN $104.39
  • Analyst Decision
  • EXAS Strong Buy
  • TTAN Buy
  • Analyst Count
  • EXAS 20
  • TTAN 14
  • Target Price
  • EXAS $70.68
  • TTAN $122.38
  • AVG Volume (30 Days)
  • EXAS 2.9M
  • TTAN 1.7M
  • Earning Date
  • EXAS 07-30-2025
  • TTAN 06-05-2025
  • Dividend Yield
  • EXAS N/A
  • TTAN N/A
  • EPS Growth
  • EXAS N/A
  • TTAN N/A
  • EPS
  • EXAS N/A
  • TTAN N/A
  • Revenue
  • EXAS $2,828,128,000.00
  • TTAN $817,242,000.00
  • Revenue This Year
  • EXAS $14.58
  • TTAN $21.17
  • Revenue Next Year
  • EXAS $12.75
  • TTAN $13.87
  • P/E Ratio
  • EXAS N/A
  • TTAN N/A
  • Revenue Growth
  • EXAS 11.57
  • TTAN 28.01
  • 52 Week Low
  • EXAS $39.97
  • TTAN $79.81
  • 52 Week High
  • EXAS $72.83
  • TTAN $131.33
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 45.95
  • TTAN N/A
  • Support Level
  • EXAS $51.50
  • TTAN N/A
  • Resistance Level
  • EXAS $53.30
  • TTAN N/A
  • Average True Range (ATR)
  • EXAS 1.62
  • TTAN 0.00
  • MACD
  • EXAS -0.64
  • TTAN 0.00
  • Stochastic Oscillator
  • EXAS 26.95
  • TTAN 0.00

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About TTAN SERVICETITAN INC

ServiceTitan Inc is an end-to-end technology platform built for contractors to transform the performance of their businesses. The Company's platform provides business owners, technicians, customer service representatives and other key office staff with technology tools designed to help customers grow revenue, drive operational efficiencies, deliver a superior end-customer experience and monitor key business drivers in real-time. The Company also has subsidiaries in Yerevan, Armenia and British Columbia, Canada that primarily serve as research and development and support centers.

Share on Social Networks: